Antibody Discovery Market Analysis 2024: Key Growth Factors And Forecast

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Antibody Discovery Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $13.21 billion In 2028 At A CAGR Of 10.2% :

The antibody discovery market size has grown rapidly in recent years. It will grow from $8.09 billion in 2023 to $8.96 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to surge in investment for drug discovery, growing investment in research and development activities, and presence of various healthcare research centers and academic institutions.

The antibody discovery market size is expected to see rapid growth in the next few years. It will grow to $13.21 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing demand for antibody drug discovery services and platforms, surge in funding for the development of novel technologies, growing demand for precision therapeutics, and broadening the utilization of antibodies beyond their conventional therapeutic roles. Major trends in the forecast period include increased research and development activities, growing demand for monoclonal antibodies, increased adoption of advanced technologies, growing demand for targeted therapeutics, and development of novel antibody formats.

Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

Antibody Discovery Market Major Segments
The antibody discovery market covered in this report is segmented -

1) By Methods: Phage Display, Hybridoma, Other Methods
2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Key Driver - Antibody Discovery Market Fueled By Rising Demand For Precision Therapeutics

The growing need for precision therapeutics is expected to propel the growth of the antibody discovery market going forward. Precision therapeutics, also known as personalized therapeutics, refers to the customization of medical treatment plans and interventions to the individual characteristics of each patient. Antibody discovery is used in precision therapeutics, enabling the development of targeted therapies, such as monoclonal antibodies, designed to interact with disease-related molecules or cells specifically and precisely for more effective and personalized treatment. For instance, in January 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022 and out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the growing need for precision therapeutics will drive the growth of the antibody discovery market.

Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=13783&type=smp

Prominent Trend - AI-Powered Platforms Revolutionize Therapeutic Development

Major companies operating in the antibody discovery market are developing innovative technologies, such as an AI-based computational antibody drug discovery platform, to improve the efficiency and precision of antibody development. An AI-based computational antibody drug discovery platform utilizes artificial intelligence and computational techniques to expedite the identification and optimization of therapeutic antibodies. For instance, in October 2023, SwiftPharma BV, a Belgium-based company developing recombinant proteins from a specialized plant-based system, introduced an AI-driven antibody discovery platform. This innovative tool combines artificial intelligence, big data, machine learning, and phage display techniques to rapidly predict high-specificity and high-affinity antibody-antigen binding. This approach, akin to natural language processing, generates diverse antibody variations, enabling SwiftPharma to create comprehensive antibody libraries efficiently. This advanced system accelerates the discovery of potential antibody drugs with unprecedented speed.

Antibody Discovery Market Players
Major companies operating in the antibody discovery market report are Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation , WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami corporation.Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies , ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the antibody discovery market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Antibody Discovery Market Report Structure
3. Antibody Discovery Market Trends And Strategies
4. Antibody Discovery Market - Macro Economic Scenario
5. Antibody Discovery Market Size And Growth
…..
27. Antibody Discovery Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.